Search

Your search keyword '"Manfrin, Erminia"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Manfrin, Erminia" Remove constraint Author: "Manfrin, Erminia" Search Limiters Full Text Remove constraint Search Limiters: Full Text
165 results on '"Manfrin, Erminia"'

Search Results

1. EUS-guided fine needle biopsy is able to provide diagnosis in rare osteoclast-like giant cells undifferentiated carcinoma of the pancreas: report of two cases

2. Endoscopic Ultrasound–guided Fine-needle Biopsy With or Without Rapid On-site Evaluation for Diagnosis of Solid Pancreatic Lesions: A Randomized Controlled Non-Inferiority Trial

3. Endoscopic Ultrasound-Guided Through-the-Needle Biopsy: A Narrative Review of the Technique and Its Emerging Role in Pancreatic Cyst Diagnosis.

4. Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model

5. Establishing the optimal number of passes during EUS-guided fine needle biopsy for the diagnosis of pancreatic solid lesions: a prospective multicente

6. Rare Pancreatic/Peripancreatic Cystic Lesions Can Be Accurately Characterized by EUS with Through-the-Needle Biopsy—A Unique Pictorial Essay with Clinical and Histopathological Correlations

8. Acinar Cystic Transformation of the Pancreas Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature

10. Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature

11. Secondary Tumors of the Pancreas: A Multicenter Analysis of Clinicopathological and Endosonographic Features

12. JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer

14. The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma

16. EUS-GUIDED FINE-NEEDLE BIOPSY WITH OR WITHOUT RAPID ON-SITE EVALUATION FOR DIAGNOSIS OF SOLID PANCREATIC LESIONS: A RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL

18. Endoscopic Ultrasound-guided Fine-needle Biopsy With or Without Rapid On-site Evaluation for Diagnosis of Solid Pancreatic Lesions: A Randomized Controlled Non-Inferiority Trial.

21. Impact of biliary stents on the diagnostic accuracy of EUS-guided fine-needle biopsy of solid pancreatic head lesions: A multicenter study

24. Additional file 3: of JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer

25. Additional file 1: of JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer

26. Additional file 2: of JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer

27. Touch imprint cytology on endoscopic ultrasound fine-needle biopsy provides comparable sample quality and diagnostic yield to standard eus-fna specimens in the evaluation of solid pancreatic lesions

28. FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma

29. Histologic retrieval rate of a newly designed side‐bevelled 20G needle for EUS‐guided tissue acquisition of solid pancreatic lesions

32. Urothelial bladder carcinoma metastasizing to the eye: A systematic review and case report

33. Centrosome Linker–induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers

34. Tumor seeding after percutaneous US-guided FNA of solid pancreatic neoplasms

35. Prognostic impact of proliferation for resected early stage ‘pure’ invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation

36. Additional file 2: of Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

37. Additional file 1: of Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

38. Additional file 3: of Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

39. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage ‘pure’ and ‘mixed’ lobular breast cancer

40. Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis

41. Urothelial bladder carcinoma metastasizing to the eye: A systematic review and case report.

42. HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy

45. Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

46. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer

50. Procedure diagnostiche (Pancreas)

Catalog

Books, media, physical & digital resources